In NSCLC, miR-4443 regulates the expres- sion ofFSP1 through METTL3 in an m6A-dependent manner, thereby inhibiting FSP1-mediated ferroptosis induced by cisplatin treatment in vitro and promoting tumor growth in vivo. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.